xDot Medical can begin FDA IDE study of vascular closure device
July 6, 2026
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).
Movmedix announced today that it received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant platform.
The CE marking by GMED recognises compliance with patient safety and clinical efficacy for Class IIb devices.
Visby’s multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.
In a new study, researchers at the Indian Institute of Science (IISc), in collaboration with clinicians at MS Ramaiah Medical College and Hospitals, explored whether low-frequency ultrasound mechanical stimulation could selectively kill oral cancer cells.
Researchers have finally identified an effective alternative for providing pain relief during the earliest phase of prehospital care, when establishing intravenous access can be difficult. The study is published in The Lancet journal.
Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool – the first in Europe and the United Kingdom to detect breast cancer using magnetic resonance imaging – which automatically identifies suspected lesions on breast MRI.
A study published in PLOS One by Yao Zhao at Temple University, U.S., and colleagues suggests that wearable devices can provide accurate, longitudinal sleep data to facilitate analyses of changing sleep patterns over time.
SINGAPORE, July 1, 2026 /PRNewswire/ — NICE Surgical Solutions Pte Ltd (“NICE Surgical”), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.
SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.